BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30240297)

  • 1. Comparison of MRI and PET as Potential Surrogate Endpoints for Treatment Response After Stereotactic Radiosurgery in Patients With Brain Metastasis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    AJR Am J Roentgenol; 2018 Dec; 211(6):1332-1341. PubMed ID: 30240297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
    Menoux I; Noël G; Namer I; Antoni D
    Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.
    Kickingereder P; Dorn F; Blau T; Schmidt M; Kocher M; Galldiks N; Ruge MI
    Radiat Oncol; 2013 Mar; 8():52. PubMed ID: 23497597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.
    Lai G; Mahadevan A; Hackney D; Warnke PC; Nigim F; Kasper E; Wong ET; Carter BS; Chen CC
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2250-5. PubMed ID: 26427832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [
    Romagna A; Unterrainer M; Schmid-Tannwald C; Brendel M; Tonn JC; Nachbichler SB; Muacevic A; Bartenstein P; Kreth FW; Albert NL
    Radiat Oncol; 2016 Oct; 11(1):139. PubMed ID: 27769279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
    Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis.
    Lohmann P; Kocher M; Ceccon G; Bauer EK; Stoffels G; Viswanathan S; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
    Neuroimage Clin; 2018; 20():537-542. PubMed ID: 30175040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery.
    Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V
    In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
    Chao ST; Suh JH; Raja S; Lee SY; Barnett G
    Int J Cancer; 2001 Jun; 96(3):191-7. PubMed ID: 11410888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis.
    Travers S; Joshi K; Miller DC; Singh A; Nada A; Biedermann G; Cousins JP; Litofsky NS
    World Neurosurg; 2021 Jul; 151():e1059-e1068. PubMed ID: 34052453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
    Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET.
    Cicone F; Carideo L; Villani V; Scaringi C; Bozzao A; Scopinaro F; Minniti G
    Clin Nucl Med; 2020 Jul; 45(7):557-558. PubMed ID: 32371619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
    Patsouris A; Augereau P; Tanguy JY; Morel O; Menei P; Rousseau A; Paumier A
    Cancer Radiother; 2014 Mar; 18(2):142-6. PubMed ID: 24433952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.